|
Volumn 27, Issue SUPPL. 60, 2000, Pages 13-16
|
Defining COX-2 inhibitors
|
Author keywords
Arthritis; Celecoxib; Cyclooxygenase; Platelet aggregation; Thromboxane; Ulcer
|
Indexed keywords
CELECOXIB;
CYCLOOXYGENASE 2 INHIBITOR;
CYCLOOXYGENASE 1;
CYCLOOXYGENASE 2;
ISOENZYME;
MEMBRANE PROTEIN;
PROSTAGLANDIN SYNTHASE;
PROSTAGLANDIN SYNTHASE INHIBITOR;
PTGS1 PROTEIN, HUMAN;
PTGS2 PROTEIN, HUMAN;
ARACHIDONIC ACID METABOLISM;
ARTHRITIS;
CONFERENCE PAPER;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG SAFETY;
DRUG SELECTIVITY;
ENZYME SPECIFICITY;
GASTROINTESTINAL SYMPTOM;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
OUTCOMES RESEARCH;
PRIORITY JOURNAL;
ANIMAL;
ARTICLE;
CLASSIFICATION;
DOSE RESPONSE;
DRUG ANTAGONISM;
ENZYMOLOGY;
METABOLISM;
OSTEOARTHRITIS;
RHEUMATOID ARTHRITIS;
ANIMALS;
ARTHRITIS, RHEUMATOID;
CYCLOOXYGENASE 1;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITORS;
CYCLOOXYGENASE INHIBITORS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HUMANS;
ISOENZYMES;
MEMBRANE PROTEINS;
OSTEOARTHRITIS;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
SUBSTRATE SPECIFICITY;
|
EID: 0034304252
PISSN: 0315162X
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (2)
|
References (16)
|